A Study of Experimental Medication BMS-986263 in Adults With Advanced Hepatic Fibrosis After Cure of Hepatitis C

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2018
This is a study of experimental medication BMS-986263 in adult patients with advanced hepatic fibrosis (scar tissue in the liver caused by inflammation that is far on in progress) after the patient is cured of hepatitis C (an infection caused by a virus that attacks the liver and leads to inflammation).
Epistemonikos ID: a2e65e1e3c1745cd57fce61ffa1456344ca52ad1
First added on: May 21, 2024